Immunophenotyping of human CD4+ and CD8+ T cell activation using flow cytometry


MBTP 54 = Miltenyi Biotec-tested panel 54

This application protocol describes the analysis of human CD4+ and CD8+ T cell activation markers after T cell stimulation. To demonstrate this state-of-the-art panel for CD4 T cell activation as well as CD8 T cell activation, PBMCs were stimulated for 48 hours using Miltenyi Biotec’s T Cell TransAct™, human. The activation state was defined by the expression level of HLA-DR, CD25, CD69, and CD38.

Protocol

Antibody panel for CD4+ and CD8+ T cell activation

SpecificityClonePurposeFluorochromeDetection filter (nm) (laser)
7-AAD*-Viability-655−730 (blue)
HLA-DRREA805T cell activationFITC525/50 (blue)
CD4REA623Helper T cellsVioGreen™525/50 (violet)
CD8REA734Cytotoxic T cellsAPC-Vio® 770750 LP (red)
CD38REA572T cell activationAPC655−730 (red)
CD3REA613T cellsVioBlue®450/50 (violet)
CD25REA570T cell activationPE585/40 (blue)
CD69REA824T cell activationPE-Vio 770750 LP (blue)

*Alternative CE-IVD/ASR reagent for 7-AAD available (# 170-100-042).

Gating strategy

Shop required products for this application protocol

8 products found

|

You have previously chosen International as your location.
What do you want to do?